$JAZZ Recent Headlines There’s good news for
Post# of 72696
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Jazz Pharmaceuticals (JAZZ) Hits New Lifetime High Today 9:46 a.m. Today - TheStreet.com
Jazz Pharmaceuticals Public (JAZZ) Earnings Report: Q3 2014 Conference Call Transcript 8:50 a.m. Today - TheStreet.com
Jazz Pharmaceuticals Public Limited's (JAZZ) CEO Bruce Cozadd on Q3 2014 Results - Earnings Call Transcript 8:20 p.m. Nov. 4, 2014 - Seeking Alpha
These 5 Drugmakers' Earnings Excelled This Quarter 7:14 p.m. Nov. 4, 2014 - Investors Business Daily
Jazz Beats And Raises Views; Regeneron Misses In Q3 6:02 p.m. Nov. 4, 2014 - Investors Business Daily
Top Funds Buy Ulta Beauty, Alexion, Avago 5:52 p.m. Nov. 4, 2014 - Investors Business Daily
10-Q: JAZZ PHARMACEUTICALS PLC 5:27 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Jazz Pharmaceuticals (JAZZ) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 4, 2014 - Seeking Alpha
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap 7:02 a.m. Nov. 4, 2014 - Investors Business Daily
Notable earnings after Tuesday's close 5:35 p.m. Nov. 3, 2014 - Seeking Alpha
Video: Alibaba Leads Top Earnings Reports On Tuesday 1:32 p.m. Nov. 3, 2014 - Investors Business Daily
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 3, 2014 - Zacks.com
IBD 50 Caps Impressive 2-Week Rally 5:47 p.m. Oct. 31, 2014 - Investors Business Daily
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings 7:21 a.m. Oct. 29, 2014 - 247WallSt.com
KKR Signals Buying Opportunities 4:03 p.m. Oct. 23, 2014 - The Wall Street Journal Interactive Edition
Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential 8:13 a.m. Oct. 21, 2014 - 247WallSt.com
Insider Trading Alert - AYI, MDSO And JAZZ Traded By Insiders 10:15 a.m. Oct. 17, 2014 - TheStreet.com
Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog 6:04 p.m. Oct. 15, 2014 - Zacks.com
Jazz Pharmaceuticals: An Attractive Play In An Attractive Industry 9:19 a.m. Oct. 13, 2014 - Seeking Alpha
Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 3:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 3:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 3:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 7:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 10:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 7:03 a.m. July 28, 2014 - BusinessWire - BZX
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)